Prognostic value of CA 19-9 in patients with pancreatic cancer treated with Gemcitabine

被引：0
|
作者：
Halm, U [1 ]
Schuhmann, T [1 ]
Keim, V [1 ]
Moessner, J [1 ]
机构：
[1] Univ Leipzig, Med Clin 2, D-7010 Leipzig, Germany
来源：
GASTROENTEROLOGY | 1999年 / 116卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G4896
引用
收藏
页码：A1129 / A1129
页数：1
相关论文
共 50 条
  • [1] Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine
    Everardo D. Saad
    Marcel C. Machado
    Dalia Wajsbrot
    Roberto Abramoff
    Paulo M. Hoff
    Jacques Tabacof
    Artur Katz
    Sergio D. Simon
    René C. Gansl
    [J]. International Journal of Gastrointestinal Cancer, 2002, 32 : 35 - 41
  • [2] Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine
    Saad, ED
    Machado, MC
    Wajsbrot, D
    Abramoff, R
    Hoff, PM
    Tabacof, J
    Katz, A
    Simon, SD
    Gansl, RC
    [J]. JOURNAL OF GASTROINTESTINAL CANCER, 2002, 32 (01) : 35 - 41
  • [3] Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine
    Ziske, C
    Schlie, C
    Gorschlüter, M
    Glasmacher, A
    Mey, U
    Strehl, J
    Sauerbruch, T
    Schmidt-Wolf, IGH
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (08) : 1413 - 1417
  • [4] Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine
    C Ziske
    C Schlie
    M Gorschlüter
    A Glasmacher
    U Mey
    J Strehl
    T Sauerbruch
    I G H Schmidt-Wolf
    [J]. British Journal of Cancer, 2003, 89 : 1413 - 1417
  • [5] Prognostic value of CA 19-9 serum course in pancreatic cancer
    Safi, F
    Schlosser, W
    Falkenreck, S
    Beger, HG
    [J]. HEPATO-GASTROENTEROLOGY, 1998, 45 (19) : 253 - 259
  • [6] CA 19-9 as a predictor of response and survival in patients with pancreatic cancer treated with gemcitabine and cisplatin based chemotherapy
    Heilbrun, L. K.
    Khanna, A.
    Venkatramanamoorthy, R.
    Shields, A. F.
    Philip, P. A.
    Zalupski, M. M.
    El-Rayes, B. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Prognostic value of CA 19-9 level in resectable pancreatic adenocarcinoma
    Rudnicki, J.
    Agrawal, A. K.
    Grzebieniak, Z.
    Zukrowski, P.
    Zysko, D.
    Jelen, M.
    Kielan, W.
    Sebastian, M.
    Slonina, J.
    Marek, G.
    Duda-Barcik, L.
    [J]. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2010, 48 (02) : 249 - 261
  • [8] Predictive and Prognostic Value of CA 19-9 in Resected Pancreatic Adenocarcinoma
    Joshua G. Barton
    John P. Bois
    Michael G. Sarr
    Christina M. Wood
    Rui Qin
    Kristine M. Thomsen
    Michael L. Kendrick
    Michael B. Farnell
    [J]. Journal of Gastrointestinal Surgery, 2009, 13 : 2050 - 2058
  • [9] Predictive and Prognostic Value of CA 19-9 in Resected Pancreatic Adenocarcinoma
    Barton, Joshua G.
    Bois, John P.
    Sarr, Michael G.
    Wood, Christina M.
    Qin, Rui
    Thomsen, Kristine M.
    Kendrick, Michael L.
    Farnell, Michael B.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2009, 13 (11) : 2050 - 2058
  • [10] Predictive and prognostic value of CA 19-9 in resected pancreatic adenocarcinoma
    Barton, Joshua G.
    Bois, John P.
    Wood, Christina M.
    Qin, Rui
    Kendrick, Michael L.
    Farnell, Michael B.
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A871 - A871
12345